Efficacy and safety of PD‐1 monoclonal antibody combined with interferon‐alpha 1b and anlotinib hydrochloride as the second‐line therapy in patients with unresectable advanced mela... by Bolun Zhao, Mengyu Zhang, Jingyi Tang, Daopei Zou, Fang Liu, Qiong Shi, Tianwen Gao, Chunying Li, Guannan Zhu

Get full text

PARP4 deficiency enhances sensitivity to ATM inhibitor by impairing DNA damage repair in melanoma by Yuehua Li, Yu Liu, Jingjing Ma, Yuqi Yang, Qiao Yue, Guannan Zhu, Weinan Guo, Tianwen Gao, Qiong Shi, Chunying Li

Get full text

A20 regulates the therapeutic effect of anti-PD-1 immunotherapy in melanoma by Lin Liu, Chen Yu, Jingjing Ma, Weinan Guo, Jinyuan Ma, Sen Guo, Huina Wang, Sijia Wang, Qiong Shi, Tao Zhao, Fengfan Yang, Shuyang Chen, Jianru Chen, Jianhong Zhao, Xiuli Yi, Yuqi Yang, Qingrong Ni, Guannan Zhu, Tianwen Gao, Chunying Li

Get full text